Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - H.C. Wainwright raised its price target on BTCS Inc. (NASDAQ:BTCS) to $7.00 from $5.00 on Friday, maintaining a Buy rating following the company’s June quarter results. The stock, currently trading at $4.50 with a market capitalization of $216 million, has delivered an impressive 256.75% return over the past year, according to InvestingPro data.
BTCS reported a 64% sequential revenue increase to $2.8 million from $1.7 million in the first quarter of 2025. The revenue growth exceeded H.C. Wainwright’s estimates, primarily driven by an 86% sequential jump in Builder+ revenue to $2.5 million, while the company’s legacy NodeOps Ethereum validator node segment remained relatively flat quarter-over-quarter. InvestingPro analysis shows the company operating with thin gross margins of 4.02%, though analysts expect 72% revenue growth for the full year 2025.
The firm noted that BTCS began its Ethereum-chain blockbuilding initiative in early 2024, which required significant spending to attract Ethereum transaction flow. This investment strategy has depressed margins in the short term but is viewed by H.C. Wainwright as "mission-critical" for BTCS’s long-term growth.
As of August 12, BTCS held 70,140 tokens valued at $321, which H.C. Wainwright pointed out represents approximately $6.70 per share in Ethereum. The firm believes BTCS has a first-mover advantage in exploiting Maximum Extractable Value (MEV) in the Ethereum ecosystem.
H.C. Wainwright stated that while BTCS shares have appreciated beyond their previous $5 price target as investors recognize the company’s scaling Ethereum balances, the market might not fully recognize revenue and income-bearing features beyond staking income. Based on InvestingPro’s Fair Value analysis, the stock appears overvalued at current levels, though the company maintains a healthy liquidity position with a current ratio of 8.19. Subscribers can access 14 additional ProTips and comprehensive financial metrics to make more informed investment decisions.
In other recent news, BTCS Inc. has successfully raised $10 million through the issuance of convertible notes, significantly expanding its Ethereum holdings to 70,028 ETH, valued at approximately $270 million. This development comes alongside the company’s filing of a legal opinion for an at-the-market offering on Nasdaq, as disclosed in a recent press release. BTCS’s inclusion in the Russell Microcap® Index has also been a notable achievement, with the index serving as a key benchmark for microcap stocks in the U.S. equity market. The company’s Ethereum holdings and liquid assets now total about $242.2 million, based on an ETH price of $3,600, reflecting a substantial increase in holdings year-to-date. Additionally, BTCS stock experienced a surge following its $10 million convertible note agreement with ATW Partners LLC. The firm has been actively increasing its Ethereum portfolio, which now holds a significant market value. Moreover, BTCS shares recently rose by 12.5% as part of a broader trend of ether-linked stocks gaining value. These developments highlight BTCS’s strategic financial maneuvers and its growing presence in the cryptocurrency sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.